Literature DB >> 12454026

Novel mutation in FOXC1 wing region causing Axenfeld-Rieger anomaly.

Shirly G Panicker1, Srirangan Sampath, Anil K Mandal, Aramati B M Reddy, Niyaz Ahmed, Seyed E Hasnain.   

Abstract

PURPOSE: To determine the possible molecular genetic defect underlying Axenfeld-Rieger anomaly (ARA) and to identify the pathogenic mutation causing this anterior segment dysgenesis in an Indian pedigree.
METHODS: The FOXC1 gene was amplified from genomic DNA of members of an ARA-affected family and control subjects using four novel sets of primers. The amplicons were directly sequenced, and the sequences were analyzed to identify the disease-causing mutation.
RESULTS: A heterozygous novel missense mutation was identified in the coding region of the FOXC1 gene in all three patients in this family. Consistent with the autosomal dominant inheritance pattern, the mutation segregated with the disease phenotype and was fully penetrant. The mutation was found in the wing region of the highly conserved forkhead domain of the FOXC1 gene and resulted in a very severe phenotype leading to blindness.
CONCLUSIONS: This is the first study to demonstrate that a mutation in the FOXC1 wing region can cause an anterior segment dysgenesis of the eye. This mutation resulted in blindness in the ARA-affected family, and the findings suggest that the FOXC1 wing region has a functional role in the normal development of the eye. Moreover, this is the first study from India to report the genetic etiology of Axenfeld-Rieger anomaly. Genotype-phenotype correlations of FOXC1 may help in establishing the disease prognosis and also in understanding the clinical and genetic heterogeneity associated with various anterior segment dysgenesis caused by this gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454026

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Essential structural and functional determinants within the forkhead domain of FOXC1.

Authors:  R A Saleem; S Banerjee-Basu; T C Murphy; A Baxevanis; M A Walter
Journal:  Nucleic Acids Res       Date:  2004-08-06       Impact factor: 16.971

2.  Targeted overexpression of TGF-α in the corneal epithelium of adult transgenic mice induces changes in anterior segment morphology and activates noncanonical Wnt signaling.

Authors:  Yong Yuan; Lung-Kun Yeh; Hongshan Liu; Osamu Yamanaka; William D Hardie; Winston W-Y Kao; Chia-Yang Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

3.  Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development.

Authors:  Konstantinos Zarbalis; Julie A Siegenthaler; Youngshik Choe; Scott R May; Andrew S Peterson; Samuel J Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

4.  Novel mutations in the FOXC1 gene in Japanese patients with Axenfeld-Rieger syndrome.

Authors:  Nobuo Fuse; Kana Takahashi; Shunji Yokokura; Kohji Nishida
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

Review 5.  Childhood glaucoma genes and phenotypes: Focus on FOXC1 mutations causing anterior segment dysgenesis and hearing loss.

Authors:  Angela C Gauthier; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2019-12-11       Impact factor: 3.467

6.  Molecular analysis of FOXC1 in subjects presenting with severe developmental eye anomalies.

Authors:  Kulvinder Kaur; Nicola K Ragge; Jiannis Ragoussis
Journal:  Mol Vis       Date:  2009-07-13       Impact factor: 2.367

7.  A Novel Homozygous Mutation in FOXC1 Causes Axenfeld Rieger Syndrome with Congenital Glaucoma.

Authors:  Shazia Micheal; Sorath Noorani Siddiqui; Saemah Nuzhat Zafar; Cristina Villanueva-Mendoza; Vianney Cortés-González; Muhammad Imran Khan; Anneke I den Hollander
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

Review 8.  Research progress on the forkhead box C1.

Authors:  Jinhua Wang; Wan Li; Xiangjin Zheng; Xiaocong Pang; Guanhua Du
Journal:  Oncotarget       Date:  2017-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.